Product Description
Zoledronic injection is a medication that is used to treat bone diseases such as osteoporosis and Paget's disease. It is a bisphosphonate, which means it works by slowing down the rate of bone breakdown and increasing bone mass. Zoledronic injection is administered intravenously, usually once a year. The most common side effects include flu-like symptoms and pain at the injection site. Serious side effects include kidney damage and severe bone, joint, and/or muscle pain. Before taking zoledronic injection, it is important to tell your doctor about all other medications and supplements you are taking.
Targeted Bone Health SolutionZoledronic Injection is specifically formulated to help prevent skeletal-related events in patients with cancer and to manage bone-related disorders such as osteoporosis and Pagets disease. Administered as a single-dose intravenous infusion, the solution acts swiftly to strengthen bones and reduce the risk of fractures.
Convenient and Safe to UsePackaged in a 100 ml glass vial and intended for prescription use only, Zoledronic Injection is ready to infuse without need for dilution. The solution must be handled by a medical professional, and all precautions should be observed to maximize safety and therapeutic effectiveness.
Comprehensive Storage and HandlingFor optimal efficacy, Zoledronic Injection should be stored refrigerated between 2C and 8C, protected from light, and never frozen. The products stability is maintained for up to 24 months, making it a reliable option for clinics and hospitals.
FAQs of Zoledronic Injection:
Q: How should Zoledronic Injection be administered?
A: Zoledronic Injection must be given by intravenous infusion only. It is provided as a ready-to-use solution in a single-dose 100 ml glass vial and should not be diluted before administration. Only a healthcare professional should administer this medication.
Q: What conditions is Zoledronic Injection used to treat?
A: This injection is indicated for the prevention and treatment of osteoporosis, Pagets disease of the bone, hypercalcemia associated with malignancy, and management of bone metastases in cancer patients. It helps reduce the risk of skeletal complications in these situations.
Q: When should Zoledronic Injection not be mixed or diluted?
A: Zoledronic Injection should never be mixed with calcium-containing solutions or diluted prior to use. It is formulated as a ready-to-use infusion and must be administered as provided to maintain its safety and effectiveness.
Q: Where should Zoledronic Injection be stored?
A: The injection should be stored in a refrigerator between 2C and 8C. Protect the vial from light and never freeze the solution to ensure its therapeutic integrity and shelf life of up to 24 months.
Q: What is the benefit of using Zoledronic Injection for bone-related disorders?
A: Zoledronic Injection is highly effective in reducing the risk of fractures and other skeletal complications, especially in cancer patients and those with osteoporosis or Pagets disease. It helps improve bone strength and overall quality of life.
Q: What precautions are necessary during the use of Zoledronic Injection?
A: The product should only be used under strict medical supervision. Patients must follow their healthcare providers instructions diligently, including undergoing necessary renal function assessments before infusion.